Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04993014
Title Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast Cancer (HER2Cell)
Acronym HER2Cell
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AC Camargo Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries BRA


No variant requirements are available.